tuberculosis vaccine (Tibet Rhodiola Pharmaceutical/Stemirna Therapeutics)

N/A

Report date: 2025/12/12 17:32:14

Base Information

Drug Nametuberculosis vaccine (Tibet Rhodiola Pharmaceutical/Stemirna Therapeutics)
Drug Alias NamemRNA vaccine (Tibet Rhodiola Pharmaceutical Holding/Stemirna Therapeutics)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesStemirna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStemirna TherapeuticsTibet Rhodiola Pharmaceutical Holding Company
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A